diabetes
Common diabetes drug can protect against age-related macular degeneration, research shows
October 31, 2018Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma
A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …
Effective preventative therapies for type 2 diabetes are underused, new research argues
October 30, 2018Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes
New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …
MSD and Samsung Bioepis terminate development of Lantus biosimilar for diabetes
October 15, 2018Research and Development, Sales and Marketing Lantus, MSD, Samsung Bioepis, Sanofi, biosimilar, diabetes, pharma
MSD has reportedly terminated a previous agreement with Samsung Bioepis which would have seen them collaborate on a biosimilar version …
Novo Nordisk’s Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients
October 12, 2018Medical Communications, Research and Development Fiasp, Novo Nordisk, Type 1 diabetes, diabetes, pharma
New data unveiled by Novo Nordisk has shown that its insulin injection Fiasp (fast-acting insulin aspart) could provide a better …
AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients
September 24, 2018Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma
AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …
AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes
August 30, 2018Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes
AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …
Novo Nordisk buys Bristol University biotech in £620m deal
August 22, 2018Research and Development Bristol, Novo Nordisk, Ziylo, diabetes
Novo Nordisk has bought a tiny biotech company spun out of Bristol University in a deal that could be worth …
Novo’s semaglutide hits the mark in Phase 3 type 2 diabetes study
August 21, 2018Manufacturing and Production, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has revealed new Phase 3a data on its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide in the treatment of …
More children suffering from type 2 diabetes in England and Wales
August 20, 2018Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people
The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …
Researchers successfully minimise diabetes drug side-effects in animal models
July 17, 2018Manufacturing and Production, Research and Development FDA, diabetes, pharma, type 2 diabetes
Researchers at the University of Pennsylvania and Syracuse University have modified a key ingredient of current diabetes drugs to produce …
Sanofi’s Toujeo proves non-inferior to insulin degludec in type 2 diabetes
June 26, 2018Manufacturing and Production, Research and Development, Sales and Marketing American Diabetes Association, Sanofi, diabetes, insulin glargine, pharma, toujeo, type 2 diabetes
Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …
Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2
June 25, 2018Research and Development, Sales and Marketing Eli Lilly, Trulicity, diabetes, pharma
Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …
FDA approves first continuous glucose monitoring system
June 22, 2018Medical Communications, Sales and Marketing FDA, diabetes, pharma
The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …
Kallyope and Novo Nordisk announce obesity and diabetes collaboration
June 20, 2018Research and Development Kallyope, Novo Nordisk, diabetes, obesity, pharma
Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the …
Eli Lilly partners with Chinese institution to advance the nation’s diabetes and CVD care
April 27, 2018Medical Communications, Research and Development China, Eli Lilly, cardiovascular disorders, cvd, diabetes, pharma, type 2 diabetes
EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …
Latest content
